Protein phosphatase 3 catalytic subunit beta mRNA (PPP3CB mRNA)

Protein phosphatase 3 catalytic subunit beta (PPP3CB) mRNA encodes the beta isoform of the catalytic subunit of calcineurin, a calcium- and calmodulin-dependent serine/threonine protein phosphatase [1, 2]. Calcineurin is a critical mediator of immune and cardiac signaling; it dephosphorylates the Nuclear Factor of Activated T-cells (NFAT), allowing it to enter the nucleus and initiate the transcription of cytokines such as interleukin-2 (IL-2) [1, 5]. While the alpha isoform (PPP3CA) is ubiquitous, the beta isoform (PPP3CB) is highly expressed in the brain and heart and has been specifically linked to pathological cardiac hypertrophy and neurodegeneration [3, 4]. Traditional drugs like cyclosporine and tacrolimus target the calcineurin protein complex but are limited by systemic toxicities, including nephrotoxicity and hypertension [5]. Consequently, PPP3CB mRNA is being investigated as a target for RNA interference (RNAi) therapies to achieve isoform-specific inhibition, potentially offering a more precise treatment for heart failure or Alzheimer's disease where calcineurin overactivation is detrimental [4, 6].

Other names

Calcineurin A beta mRNACNA2 mRNACALNB mRNAPPP3B mRNAProtein phosphatase 2B catalytic subunit beta mRNA

Inhibition of phosphatase activity via immunophilin binding (protein-level); RNA interference or antisense-mediated transcript degradation (mRNA-level).